Tango Therapeutics President, R&D Crystal Adam disposes of $661,799 in common shares
TNGX•Crystal Adam exercised options for 27,000 Tango Therapeutics shares at $5.20 on Oct. 1, 2026, and sold 27,000 shares the same day at weighted average prices of $24.4547 and $25.32. Her direct holding fell to 115,743 shares.
1. Share transactions
Tango Therapeutics President, R&D Crystal Adam exercised stock options for 27,000 shares at $5.20 on Oct. 1, 2026, and sold 27,000 shares that day at weighted average prices of $24.4547 and $25.32. Her direct holding fell to 115,743 shares following the transactions.
